How much does Leqembi (Lecanemab Injection) Cost& price without insurance in China?
Leqembi® is the commercial brand name of Lecanemab Injection, a humanized monoclonal antibody jointly developed by Eisai and Biogen. It targets soluble aggregated amyloid-beta in the brain to clear cerebral amyloid deposits and slow disease progression of Alzheimer’s disease.
Main Indications
Treatment of adult patients with early Alzheimer’s disease confirmed with positive amyloid pathology.
Common Side Effects
Common mild adverse reactions: Headache, infusion-related reactions and fatigue.
Laboratory abnormalities: Transient abnormal brain imaging findings without clinical symptoms.
Severe but manageable risks: Amyloid-related imaging abnormalities with hemorrhage or edema and severe hypersensitivity reactions.
Approval Status in China
Leqembi® (Lecanemab Injection, 200mg/2mL) was officially approved for marketing in China in 2024. It is currently a prescription medicine included in China’s Category B medical insurance.
Buy Leqembi (Lecanemab Injection) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
